US · LFST · MEDICAL - CARE FACILITIES
LifeStance Health Group, Inc. (LFST) intrinsic value and stock valuation
$13.82as of 2026-11-21 · Mkt cap 4.2B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
LifeStance Health Group, Inc. DCF and intrinsic value
InvestorsCraft values LFST with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from LFST’s statements →
LifeStance Health Group, Inc. Graham Number
Graham Number: $1.49d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2019–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Brookdale Senior Living Inc. (BKD) $8.86
- Acadia Healthcare Company, Inc. (ACHC) $34.60
- Clover Health Investments, Corp. (CLOV) $3.73
- Addus HomeCare Corporation (ADUS) $122.50
- Pediatrix Medical Group, Inc. (MD) $30.22
- Aveanna Healthcare Holdings Inc. (AVAH) $11.01
- Astrana Health, Inc. (ASTH) $28.90
- Ardent Health Inc. (ARDT) $15.08
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M |
| Operating income | $24.2M | -$-31.61M | -$-189.13M | -$-210.17M | -$-286.35M |
| Net income | $9.66M | -$-57.44M | -$-186.26M | -$-215.56M | -$-307.2M |
| EPSd | $24.7K | -$-151.5K | -$-506.89K | -$-606.73K | -$-937.96K |
| Operating cash flow | $146.2M | $107.3M | -$-16.88M | $52.8M | $9.42M |
| Capital expenditure | -$-36.12M | -$-21.57M | -$-40.52M | -$-79.25M | -$-94.49M |
| Free cash flow | $110M | $85.7M | -$-57.4M | -$-26.47M | -$-85.07M |
| Total assets | $2.2B | $2.12B | $2.11B | $2.17B | $1.93B |
| Total debt | $194.1M | $485.2M | $511M | $478.8M | $158.7M |
| Net debt | -$-54.55M | $330.6M | $432.2M | $370.2M | $10.7M |
| Total equity | $1.52B | $1.45B | $1.43B | $1.52B | $1.55B |
| Cash and short-term investments | $248.6M | $154.6M | $78.8M | $108.6M | $148M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M |
| Cost of revenue | $963.2M | $848.6M | $753.6M | $622.5M | $466M |
| Gross profit | $461.1M | $402.4M | $302.1M | $237M | $201.5M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $382.2M | $363.1M | $410.8M | $378M | $433.7M |
| Other expenses | $54.8M | $71M | $80.4M | $69.2M | $54.1M |
| Operating expenses | $437M | $434M | $491.2M | $447.2M | $487.9M |
| Cost and expenses | $1.4B | $1.28B | $1.24B | $1.07B | $953.9M |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $11.7M | $26.5M | $21.2M | $19.9M | $38.9M |
| Depreciation and amortization | $54.8M | $71M | $80.4M | $69.2M | $54.1M |
| Ebitda | $78.8M | $39.9M | -$-104.93M | -$-143.6M | -$-240.06M |
| Operating income | $24.2M | -$-31.61M | -$-189.13M | -$-210.17M | -$-286.35M |
| Total other income/expenses, net | -$-11.79M | -$-26M | -$-17.45M | -$-22.56M | -$-46.75M |
| Income before tax | $12.4M | -$-57.61M | -$-206.58M | -$-232.73M | -$-333.11M |
| Income tax expense | $2.7M | -$-170K | -$-20.32M | -$-17.17M | -$-25.91M |
| Net income | $9.66M | -$-57.44M | -$-186.26M | -$-215.56M | -$-307.2M |
| Weighted average shares outstanding | $386M | $379.2M | $367.5M | $355.3M | $327.5M |
| Weighted average diluted shares outstanding | $391.1M | $379.2M | $367.5M | $355.3M | $327.5M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $248.6M | $154.6M | $78.8M | $108.6M | $148M |
| Net receivables | $95.7M | $132M | $125.6M | $101.5M | $99.3M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $38.1M |
| Total current assets | $416.2M | $312.5M | $225.7M | $233.2M | $266.5M |
| Property, plant and equipment, net | $311.3M | $313.9M | $358.9M | $393.6M | $152.2M |
| Goodwill and intangible assets | $1.47B | $1.48B | $1.51B | $1.54B | $1.5B |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | -$-42.56M |
| Total non-current assets | $1.79B | $1.81B | $1.88B | $1.94B | $1.66B |
| Total assets | $2.2B | $2.12B | $2.11B | $2.17B | $1.93B |
| Accounts payable | $6.12M | $7.24M | $23.2M | $24.4M | $14.2M |
| Short-term debt | $45.5M | $56.7M | $49.4M | $41.2M | $1.32M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $76.1M |
| Total current liabilities | $252M | $228.9M | $202.9M | $176M | $116.8M |
| Long-term debt | $148.6M | $428.5M | $461.6M | $437.7M | $157.4M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $431M | $443.1M | $478.2M | $479.2M | $265.3M |
| Capital lease obligations | $0.00 | $198.2M | $227.8M | $251.4M | $0.00 |
| Total liabilities | $682.9M | $672M | $681M | $655.2M | $382.1M |
| Common stock | $3.88M | $3.83M | $3.79M | $3.76M | $3.74M |
| Retained earnings | -$-808.63M | -$-818.29M | -$-760.85M | -$-572.64M | -$-357.07M |
| Accumulated other comprehensive income (loss) | $0.00 | $930K | $2.3M | $3.27M | $0.00 |
| Total equity | $1.52B | $1.45B | $1.43B | $1.52B | $1.55B |
| Total investments | $0.00 | $0.00 | $0.00 | $0.00 | -$-42.56M |
| Total debt | $194.1M | $485.2M | $511M | $478.8M | $158.7M |
| Net debt | -$-54.55M | $330.6M | $432.2M | $370.2M | $10.7M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $9.66M | -$-57.44M | -$-186.26M | -$-215.56M | -$-307.2M |
| Depreciation and amortization | $54.8M | $71M | $80.4M | $69.2M | $54.1M |
| Stock-based compensation | $74.7M | $76.2M | $99.4M | $187.4M | $259.4M |
| Change in working capital | -$-40.34M | -$-27.37M | -$-33.72M | -$-16.94M | $2.14M |
| Accounts receivable | $36.1M | -$-6.4M | -$-24.18M | -$-21.66M | -$-24.21M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-1.56M | $500K | -$-5.61M | $7.67M | $620K |
| Net cash provided by operating activities | $146.2M | $107.3M | -$-16.88M | $52.8M | $9.42M |
| Investments in property, plant and equipment | -$-36.12M | -$-21.57M | -$-40.52M | -$-79.25M | -$-94.49M |
| Acquisitions, net | $0.00 | $0.00 | -$-19.82M | -$-60.21M | -$-99.58M |
| Net cash used for investing activities | -$-36.12M | -$-21.57M | -$-60.34M | -$-139.46M | -$-194.08M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $549.9M |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | -$-900K | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-15.96M | -$-9.95M | $47.4M | $47.3M | $313.9M |
| Net change in cash | $94.1M | $75.8M | -$-29.8M | -$-39.41M | $129.2M |
| Cash at end of period | $248.6M | $154.6M | $78.8M | $108.6M | $148M |
| Operating cash flow | $146.2M | $107.3M | -$-16.88M | $52.8M | $9.42M |
| Capital expenditure | -$-36.12M | -$-21.57M | -$-40.52M | -$-79.25M | -$-94.49M |
| Free cash flow | $110M | $85.7M | -$-57.4M | -$-26.47M | -$-85.07M |
Line items
Line items
Line items
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
- CEO
- David Patrick Bourdon
- Employees
- 10.96K
- Beta
- 1.12
Explore
Frequently asked questions
What is the intrinsic value of LifeStance Health Group, Inc. (LFST)?
LifeStance Health Group, Inc. (LFST) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is LFST undervalued?
LFST trades at a price of $13.82 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.